tm logo
DYSPORT THERAPEUTIC
REGISTERED

on 30 Nov 2018

Last Applicant/ Owned by

IPSEN BIOPHARM LIMITED

Ash RoadWrexham Industrial EstateWrexham LL13 9UF

GB

Serial Number

1793786 filed on 29th Jul 2016

Registration Number

TMA1010181 registered on 30th Nov 2018

Registration expiry Date

30th Nov 2033

Correspondent Address

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

DYSPORT THERAPEUTIC

Trademark usage description

pharmaceutical preparations for the treatment of muscular disorders, namely motor disorders, muscular atrophy, muscular dystrophy, dystonias, muscular Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of muscular disorders, namely motor disorders, muscular atrophy, muscular dystrophy, dystonias, muscular dystonia, cervical dystonia, spasticity of the lower limbs, muscular spasm, blepharospasm, spasmodic torticollis, hemifacial spasm, muscle cramp, dynamic equinus foot deformity; pharmaceutical preparations for use in the treatment of neurological diseases, namely medicines nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, focal dystonia, cervical dystonia; pharmaceutical preparations for the treatment of cerebral palsy, spasticity; pharmaceutical preparations containing botulinum toxin with specified component(s) of the toxin-haemagglutin complex, namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for the treatment of neurological disorders namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia; pharmaceutical preparations containing botulinum toxin with specified component(s) of the toxin-haemagglutin complex for the treatment of neurological disorders namely medicines for nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, cervical dystonia, cerebral palsy, movement disorders, focal dystonia.


Classification kind code

10

Mark Details


Serial Number

1793786

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 55
on 30th Nov 2018
Registered
Submitted for opposition 50
on 01st Sep 2017
Allowed
Submitted for opposition 51
on 01st Sep 2017
Allowance Notice Sent
Submitted for opposition 42
on 17th May 2017
Advertised
Submitted for opposition 26
on 27th Apr 2017
Approved
Submitted for opposition 22
on 06th Mar 2017
Search Recorded
Submitted for opposition 27
on 06th Mar 2017
Approval Notice Sent
Submitted for opposition 31
on 03rd Aug 2016
Formalized
Submitted for opposition 1
on 01st Aug 2016
Created
Submitted for opposition 30
on 29th Jul 2016
Filed